Guidance published on AI assisted tools for prostate cancer diagnosis
We have published new guidance on artificial intelligence (AI) assisted review of prostate biopsies in the detection and diagnosis of prostate cancer.
According to our guidance, there is insufficient evidence to support the routine adoption of the technology.
The guidance recommends further research to understand the clinical and cost-effectiveness of the AI systems and their impact on real-world clinical practice. In particular, we would support the analysis of data from an ongoing pilot project using an AI system for prostate cancer diagnosis in NHS Wales.
To read the guidance in full click here: We have published new guidance on artificial intelligence (AI) assisted review of prostate biopsies in the detection and diagnosis of prostate cancer.
According to our guidance, there is insufficient evidence to support the routine adoption of the technology.
The guidance recommends further research to understand the clinical and cost-effectiveness of the AI systems and their impact on real-world clinical practice. In particular, we would support the analysis of data from an ongoing pilot project using an AI system for prostate cancer diagnosis in NHS Wales.
To read the guidance in full click here: